These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36705027)

  • 1. Comparison of outcome among type 2 vs type 1 myocardial infarction: a systematic review and meta-analysis.
    Jaiswal V; Ang SP; Ishak A; Nasir YM; Chia JE; Naz S; Jaiswal A
    J Investig Med; 2023 Mar; 71(3):223-234. PubMed ID: 36705027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis.
    White K; Kinarivala M; Scott I
    BMJ Open; 2022 Feb; 12(2):e055755. PubMed ID: 35177458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study.
    Greenslade JH; Adikari T; Mueller C; Sandoval Y; Nestelberger T; Parsonage W; Hawkins T; Cullen L
    Emerg Med J; 2018 Mar; 35(3):169-175. PubMed ID: 28784608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 myocardial infarction: A descriptive analysis and comparison with type 1 myocardial infarction.
    Landes U; Bental T; Orvin K; Vaknin-Assa H; Rechavia E; Iakobishvili Z; Lev E; Assali A; Kornowski R
    J Cardiol; 2016 Jan; 67(1):51-6. PubMed ID: 25956551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-month cardiovascular prognostic impact of type 1 And type 2 myocardial infarction in patients hospitalized for gastrointestinal bleeding.
    Pemmasani G; Ashwath A; Aronow WS; Yandrapalli S; Leighton J; John S
    Eur J Intern Med; 2023 Oct; 116():51-57. PubMed ID: 37500309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort.
    Raphael CE; Roger VL; Sandoval Y; Singh M; Bell M; Lerman A; Rihal CS; Gersh BJ; Lewis B; Lennon RJ; Jaffe AS; Gulati R
    Circulation; 2020 Feb; 141(6):454-463. PubMed ID: 31902228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis.
    Vargas KG; Haller PM; Jäger B; Tscharre M; Binder RK; Mueller C; Lindahl B; Huber K
    Clin Res Cardiol; 2019 Jul; 108(7):749-762. PubMed ID: 30535801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS).
    Feinstein MJ; Nance RM; Delaney JAC; Heckbert SR; Budoff MJ; Drozd DR; Burkholder GA; Willig JH; Mugavero MJ; Mathews WC; Moore RD; Eron JJ; Napravnik S; Hunt PW; Geng E; Hsue P; Peter I; Lober WB; Crothers K; Grunfeld C; Saag MS; Kitahata MM; Lloyd-Jones DM; Crane HM
    BMC Med; 2019 Jul; 17(1):149. PubMed ID: 31362721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data.
    Wasfy JH; Price M; Normand ST; Januzzi JL; McCarthy CP; Hsu J
    Circ Cardiovasc Qual Outcomes; 2024 Feb; 17(2):e009986. PubMed ID: 38240159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 myocardial infarction: incidence, presentation, treatment and outcome in routine clinical practice.
    Radovanovic D; Pilgrim T; Seifert B; Urban P; Pedrazzini G; Erne P
    J Cardiovasc Med (Hagerstown); 2017 May; 18(5):341-347. PubMed ID: 28107211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and outcomes of high bleeding risk patients with type 1 and type 2 myocardial infarction in a community-based cohort: Application of the Academic Research Consortium High Bleeding Risk Criteria.
    Breen TJ; Raphael CE; Ingraham B; Lane C; Huxley S; Roger VL; Jaffe A; Lewis B; Sandoval YB; Prasad A; Rihal CS; Gulati R; Singh M
    Int J Cardiol; 2024 Feb; 396():131565. PubMed ID: 37913957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction.
    Horiuchi Y; Wettersten N; Patel MP; Mueller C; Neath SX; Christenson RH; Morgenthaler NG; McCord J; Nowak RM; Vilke GM; Daniels LB; Hollander JE; Apple FS; Cannon CM; Nagurney JT; Schreiber D; deFilippi C; Hogan C; Diercks DB; Headden G; Limkakeng AT; Anand I; Wu AHB; Ebmeyer S; Jaffe AS; Peacock WF; Maisel A
    Circulation; 2020 Oct; 142(16):1532-1544. PubMed ID: 32820656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid-related protein 8/14 and high-sensitivity cardiac troponin I to differentiate type 2 myocardial infarction.
    Bormann J; Psyrakis DA; von Jeinsen B; Grün D; Elsner LK; Wolter JS; Weferling M; Diouf K; Kriechbaum S; Troidl C; Dörr O; Nef H; Hamm CW; Liebetrau C; Keller T
    Int J Cardiol; 2020 Apr; 304():144-147. PubMed ID: 32008845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of Type 2 Myocardial Infarction and Readmission With Type 1 Myocardial Infarction in Hypertensive Crises (from a Nationwide Analysis).
    Maraey A; Elzanaty AM; Salem M; Khalil M; Elsharnoby H; Younes A; Elsharnouby M; Nazir S; Elgendy IY; Siragy HM
    Am J Cardiol; 2021 Dec; 161():56-62. PubMed ID: 34794619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of high-sensitivity cardiac troponin T and I in the early differentiation of type 1 vs. type 2 myocardial infarction.
    Nestelberger T; Boeddinghaus J; Giménez MR; Lopez-Ayala P; Ratmann PD; Badertscher P; Wildi K; Wussler D; Koechlin L; Arslani K; Zimmermann T; Freese M; Rinderknecht T; Miró Ò; Martin-Sanchez FJ; Kawecki D; Geigy N; Keller D; Twerenbold R; Müller C;
    Eur Heart J Acute Cardiovasc Care; 2022 Jan; 11(1):62-74. PubMed ID: 34195803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination of patients with type 2 myocardial infarction.
    Neumann JT; Sörensen NA; Rübsamen N; Ojeda F; Renné T; Qaderi V; Teltrop E; Kramer S; Quantius L; Zeller T; Karakas M; Blankenberg S; Westermann D
    Eur Heart J; 2017 Dec; 38(47):3514-3520. PubMed ID: 29020401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of depression on in-hospital outcomes for adults with type 2 myocardial infarction: A United States population-based analysis.
    Neppala S; Chigurupati HD; Chauhan S; Chinthapalli MT; Desai R
    World J Cardiol; 2024 Jul; 16(7):412-421. PubMed ID: 39086894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-based differences in clinical outcomes and resource utilization of type 2 myocardial infarction.
    Ariss RW; Elzanaty AM; Minhas AMK; Nazir S; Gul S; Patel N; Ahuja KR; Mochon A; Eltahawy EA
    Int J Cardiol; 2021 Sep; 338():24-29. PubMed ID: 34058288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute versus chronic myocardial injury and long-term outcomes.
    Kadesjö E; Roos A; Siddiqui A; Desta L; Lundbäck M; Holzmann MJ
    Heart; 2019 Dec; 105(24):1905-1912. PubMed ID: 31337668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet Therapy.
    Reid C; Alturki A; Yan A; So D; Ko D; Tanguay JF; Bessissow A; Mehta S; Goodman S; Huynh T
    CJC Open; 2020 May; 2(3):118-128. PubMed ID: 32462125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.